Depression is a common mental disorder. Some 300 million people in the world have it, or an estimated 3.8% of the population, ...

A University of Queensland-led team analyzed data for 204 countries and territories, to assess global access to adequate ...

Major depressive disorder (MDD), commonly referred to as depression, is a serious medical condition that affects a person's ...

Psilocybin effects on depression and anxiety are generally safe and well-tolerated, but researchers should focus on determining optimal dosage.

Bright light therapy has shown significant promise in improving remission and response rates among patients with nonseasonal ...

In contrast to electroconvulsive therapy, patients are not sedated during the treatments. Studies of a protocol called ...

A study published in the Journal of Affective Disorders proposes a novel, fully automated artificial intelligence (AI) ...

Scientists found disrupted brain connectivity in youth depression, especially in networks tied to introspection and attention ...

Twelve months after two 16 mg doses of the drug, called CYB003, seven patients saw their scores improve on the ...

Cybin, Inc. ( (CYBN) ) has released its Q2 earnings. Here is a breakdown of the information Cybin, Inc. presented to its investors.Don't Miss ...

In the fall and winter seasons, this is an everyday occurrence for those with Seasonal Affective Disorder (SAD), a form of ...

Researchers have found 70 per cent of Australians diagnosed with major depressive disorder are not receiving even the minimal treatment necessary.